Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CPF-R.BK Stock Summary
Top 10 Correlated ETFs
CPF-R.BK
In the News
CPF-R.BK Financial details
Company Rating
Neutral
Market Cap
155.3B
Income
-5.43B
Revenue
585.84B
Book val./share
25.78
Cash/share
3.31
Dividend
0.35
Dividend %
1.83%
Employees
-
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-42.22
Forward P/E
17.2
PEG
2.99
P/S
0.25
P/B
0.63
P/C
5.56
P/FCF
-218.82
Quick Ratio
0.24
Current Ratio
0.79
Debt / Equity
2.41
LT Debt / Equity
1.22
-
-
EPS (TTM)
-0.69
EPS next Y
1.07
EPS next Q
-
EPS this Y
-144.38%
EPS next Y
-253.77%
EPS next 5Y
-315.82%
EPS last 5Y
NAN%
Revenue last 5Y
1.92%
Revenue Q/Q
1.95%
EPS Q/Q
-94.48%
-
-
-
-
SMA20
-
SMA50
-1.65%
SMA100
-5.18%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-1%
ROC
-0.01%
Gross Margin
11%
Oper. Margin
-1%
Profit Margin
-1%
Payout
-560%
Shs Outstand
8.44B
Shs Float
4.48B
-
-
-
-
Target Price
-
52W Range
18.4-22.1
52W High
-16.36%
52W Low
+2.22%
RSI
48.07
Rel Volume
-
Avg Volume
-
Volume
2.14M
Perf Week
-2.13%
Perf Month
2.79%
Perf Quarter
-5.64%
Perf Half Y
-5.64%
-
-
-
-
Beta
0.279
-
-
Volatility
0.11%, 0.32%
Prev Close
1.1%
Price
18.4
Change
0%
CPF-R.BK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 65.07 | 72.76 | 64.33 | 77.39 | 74.93 | |
Net income per share | 2.25 | 3.21 | 1.63 | 1.76 | -0.75 | |
Operating cash flow per share | 4.96 | 8.76 | 0.81 | 4.23 | 2.09 | |
Free cash flow per share | 1.79 | 5.41 | -2.26 | 0.74 | -0.76 | |
Cash per share | 4.09 | 7.16 | 5.05 | 4.56 | 3.48 | |
Book value per share | 20.56 | 23.68 | 26.98 | 32.26 | 27.18 | |
Tangible book value per share | 14.26 | 23.99 | 26.68 | 28.18 | 23.62 | |
Share holders equity per share | 20.56 | 23.68 | 26.98 | 32.26 | 27.18 | |
Interest debt per share | 42.48 | 51.64 | 58.63 | 65.96 | 68.79 | |
Market cap | 193.17B | 191.28B | 188.09B | 187.29B | 150.91B | |
Enterprise value | 494.97B | 550.35B | 616.02B | 674.89B | 666.66B | |
P/E ratio | 10.47 | 7.35 | 14.44 | 13.41 | -25.85 | |
Price to sales ratio | 0.36 | 0.32 | 0.37 | 0.3 | 0.26 | |
POCF ratio | 4.76 | 2.69 | 29.3 | 5.58 | 9.21 | |
PFCF ratio | 13.2 | 4.36 | -10.43 | 31.75 | -25.45 | |
P/B Ratio | 1.15 | 1 | 0.87 | 0.73 | 0.71 | |
PTB ratio | 1.15 | 1 | 0.87 | 0.73 | 0.71 | |
EV to sales | 0.93 | 0.93 | 1.2 | 1.1 | 1.14 | |
Enterprise value over EBITDA | 9.06 | 7.78 | 20.43 | 15.28 | 17.29 | |
EV to operating cash flow | 12.19 | 7.75 | 95.95 | 20.12 | 40.7 | |
EV to free cash flow | 33.82 | 12.54 | -34.16 | 114.41 | -112.43 | |
Earnings yield | 0.1 | 0.14 | 0.07 | 0.07 | -0.04 | |
Free cash flow yield | 0.08 | 0.23 | -0.1 | 0.03 | -0.04 | |
Debt to equity | 1.98 | 2.17 | 2.16 | 2.03 | 2.41 | |
Debt to assets | 0.53 | 0.55 | 0.55 | 0.56 | 0.58 | |
Net debt to EBITDA | 5.52 | 5.08 | 14.19 | 11.04 | 13.38 | |
Current ratio | 0.9 | 0.95 | 1.06 | 0.87 | 0.81 | |
Interest coverage | 2.73 | 19.6 | 2.86 | 6.65 | 0.21 | |
Income quality | 1.69 | 1.61 | 0.46 | 2.33 | -2.81 | |
Dividend Yield | 0.03 | 0.03 | 0.04 | 0.03 | 0.02 | |
Payout ratio | 0.27 | 0.25 | 0.61 | 0.37 | -0.61 | |
Sales general and administrative to revenue | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.16 | 0.09 | 0.09 | 0.08 | 0.1 | |
Capex to operating cash flow | -0.64 | -0.38 | -3.81 | -0.82 | -1.36 | |
Capex to revenue | -0.05 | -0.05 | -0.05 | -0.05 | -0.04 | |
Capex to depreciation | -1.53 | -1.22 | -1.09 | -1.11 | -0.67 | |
Stock based compensation to revenue | -0.03 | -0.04 | -0.04 | -0.02 | -0.1 | |
Graham number | 32.3 | 41.36 | 31.5 | 35.75 | 21.37 | |
ROIC | 0.06 | 0.06 | 0.01 | 0.02 | 0.01 | |
Return on tangible assets | 0.03 | 0.04 | 0.02 | 0.02 | -0.01 | |
Graham Net | -37.57 | -45.74 | -53.4 | -61.69 | -64.64 | |
Working capital | -19.07B | -9.48B | 12.62B | -33.76B | -50.35B | |
Tangible asset value | 116.71B | 194.47B | 212.67B | 223.62B | 171.6B | |
Net current asset value | -236.53B | -304.87B | -338.99B | -393.92B | -420B | |
Invested capital | 1.98 | 2.17 | 2.16 | 2.03 | 2.41 | |
Average receivables | 37.22B | 33.6B | 36.19B | 41.02B | 43.43B | |
Average payables | 33.82B | 32.25B | 38.34B | 47.67B | 43.75B | |
Average inventory | 96.2B | 94.58B | 106.22B | 129.5B | 132.65B | |
Days sales outstanding | 22.94 | 20.87 | 27.52 | 25.78 | 27.09 | |
Days payables outstanding | 25.93 | 24.43 | 36.05 | 35.04 | 25.41 | |
Days of inventory on hand | 79.03 | 68.85 | 98.63 | 94.61 | 88.84 | |
Receivables turnover | 15.91 | 17.49 | 13.26 | 14.16 | 13.47 | |
Payables turnover | 14.08 | 14.94 | 10.12 | 10.42 | 14.36 | |
Inventory turnover | 4.62 | 5.3 | 3.7 | 3.86 | 4.11 | |
ROE | 0.11 | 0.14 | 0.06 | 0.05 | -0.03 | |
Capex per share | -3.17 | -3.35 | -3.07 | -3.48 | -2.85 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 20.05 | 18.21 | 19.13 | 18.59 | 17.87 | |
Net income per share | 0.23 | -0.35 | -0.1 | -0.23 | -0.01 | |
Operating cash flow per share | 0.17 | 0.74 | 0.55 | 1.38 | 1.08 | |
Free cash flow per share | -0.76 | 0.15 | -0.16 | 0.7 | 0.27 | |
Cash per share | 4.57 | 3.55 | 3.26 | 3.21 | 3.31 | |
Book value per share | 32.28 | 31.36 | 30.4 | 30.35 | 25.78 | |
Tangible book value per share | 28.19 | 27.49 | 26.5 | 26.26 | 22.4 | |
Share holders equity per share | 32.28 | 31.36 | 30.4 | 30.35 | 25.78 | |
Interest debt per share | 65.72 | 65.36 | 67.09 | 68.84 | 62.95 | |
Market cap | 187.22B | 171.34B | 164.89B | 151.57B | 159.08B | |
Enterprise value | 674.82B | 662.07B | 667.2B | 663B | 674.83B | |
P/E ratio | 25.84 | -15.72 | -52.03 | -20.93 | -379.01 | |
Price to sales ratio | 1.18 | 1.19 | 1.1 | 1.05 | 1.08 | |
POCF ratio | 137.42 | 29.39 | 37.95 | 14.08 | 17.81 | |
PFCF ratio | -31.1 | 145.7 | -130.41 | 27.92 | 71.65 | |
P/B Ratio | 0.73 | 0.69 | 0.69 | 0.64 | 0.75 | |
PTB ratio | 0.73 | 0.69 | 0.69 | 0.64 | 0.75 | |
EV to sales | 4.24 | 4.6 | 4.44 | 4.59 | 4.58 | |
Enterprise value over EBITDA | 218.96 | 121.72 | 91.26 | 5.88K | 92.78 | |
EV to operating cash flow | 495.33 | 113.57 | 153.55 | 61.59 | 75.56 | |
EV to free cash flow | -112.11 | 563 | -527.68 | 122.11 | 303.93 | |
Earnings yield | 0.01 | -0.02 | 0 | -0.01 | 0 | |
Free cash flow yield | -0.03 | 0.01 | -0.01 | 0.04 | 0.01 | |
Debt to equity | 2.03 | 2.08 | 2.2 | 2.27 | 2.41 | |
Debt to assets | 0.56 | 0.57 | 0.58 | 0.59 | 0.58 | |
Net debt to EBITDA | 158.21 | 90.22 | 68.7 | 4.54K | 70.91 | |
Current ratio | 0.87 | 0.89 | 0.81 | 0.79 | 0.81 | |
Interest coverage | 2.42 | -3.62 | -1.22 | -3.02 | -0.23 | |
Income quality | 0.73 | -2.08 | -16.33 | -8.9 | -85.11 | |
Dividend Yield | 0.09 | 0 | 0.02 | 0 | 0.01 | |
Payout ratio | 9.35 | 0 | -3.49 | 0 | -7.66 | |
Sales general and administrative to revenue | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.08 | 0.08 | 0.08 | 0.08 | 0.1 | |
Capex to operating cash flow | -5.42 | -0.8 | -1.29 | -0.5 | -0.75 | |
Capex to revenue | -0.05 | -0.03 | -0.04 | -0.04 | -0.05 | |
Capex to depreciation | -6.17 | -0.58 | -0.69 | -2.31 | -0.76 | |
Stock based compensation to revenue | -0.02 | 0 | -0.02 | -0.02 | -0.05 | |
Graham number | 12.88 | 15.61 | 8.31 | 12.61 | 2.72 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | -61.72 | -62.08 | -62.96 | -64.99 | -61.32 | |
Working capital | -33.76B | -27.22B | -52.81B | -57.53B | -50.35B | |
Tangible asset value | 223.62B | 217.03B | 208.1B | 204.13B | 171.6B | |
Net current asset value | -393.92B | -395.19B | -400.18B | -410.99B | -420B | |
Invested capital | 2.03 | 2.08 | 2.2 | 2.27 | 2.41 | |
Average receivables | 42.22B | 41.84B | 40.62B | 40.89B | 42.16B | |
Average payables | 48.69B | 48.77B | 43.35B | 40.27B | 38.47B | |
Average inventory | 138.94B | 137.02B | 138.06B | 138.71B | 132.7B | |
Days sales outstanding | 24.55 | 25.22 | 24.53 | 25.43 | 26.57 | |
Days payables outstanding | 32.51 | 32.68 | 27.33 | 28.28 | 24.58 | |
Days of inventory on hand | 87.78 | 95.73 | 95.16 | 96.36 | 85.92 | |
Receivables turnover | 3.67 | 3.57 | 3.67 | 3.54 | 3.39 | |
Payables turnover | 2.77 | 2.75 | 3.29 | 3.18 | 3.66 | |
Inventory turnover | 1.03 | 0.94 | 0.95 | 0.93 | 1.05 | |
ROE | 0.01 | -0.01 | 0 | -0.01 | 0 | |
Capex per share | -0.93 | -0.59 | -0.71 | -0.69 | -0.81 |
CPF-R.BK Frequently Asked Questions
What is Charoen Pokphand Foods Public Company Limited stock symbol ?
Charoen Pokphand Foods Public Company Limited is a TH stock and trading under the symbol CPF-R.BK
What is Charoen Pokphand Foods Public Company Limited stock quote today ?
Charoen Pokphand Foods Public Company Limited stock price is $18.4 today.
Is Charoen Pokphand Foods Public Company Limited stock public?
Yes, Charoen Pokphand Foods Public Company Limited is a publicly traded company.